
|Videos|May 9, 2022
Leptomeningeal Metastases in HER2+ Breast Cancer
A neuro-oncologist explains the prevalence of leptomeningeal metastases in HER2+ breast cancer and her preferred method of treatment.
Advertisement
Episodes in this series

Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
All-Oral Revumenib Regimen May Show Advantage in Newly Diagnosed AML
2
Blinatumomab/Ponatinib Provides Chemo-Free Option in Ph+ ALL
3
Talquetamab Combo Yields Responses in Multiple Myeloma With True EMD
4
Linvoseltamab Yields High Response in Newly Diagnosed Multiple Myeloma
5






















































































